China's Market Approval Policy and Medical Insurance Payment System for Rare Disease
Related Insights
Blog
Unpacking NICE’s review of the HST routing criteria: implications for manufacturers
Oct 3, 2024
Blog
Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress
May 2, 2024
Podcast
Why Rare Disease Therapeutics Need Early Market Access Planning
Jan 4, 2023
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Pragmatic Trials: Targeting evidence generation to inform market access and meet payers’ needs
Feb 8, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Article
EU Orphan Drug Designation – overcoming regulatory challenges
Jul 20, 2022
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Rachel Smith joins Parexel as Executive Director and Head of the Rare Disease, Center of Excellence
Aug 10, 2022
Related Insights
Blog
Unpacking NICE’s review of the HST routing criteria: implications for manufacturers
Oct 3, 2024
Blog
Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress
May 2, 2024
Podcast
Why Rare Disease Therapeutics Need Early Market Access Planning
Jan 4, 2023
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Pragmatic Trials: Targeting evidence generation to inform market access and meet payers’ needs
Feb 8, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Article
EU Orphan Drug Designation – overcoming regulatory challenges
Jul 20, 2022
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Rachel Smith joins Parexel as Executive Director and Head of the Rare Disease, Center of Excellence
Aug 10, 2022